Showing results (71-80 of 235) with videos related to

Sort By:
Pageof 24
JAMA Internal Medicine|April 19, 2021
Association of US Food and Drug Administration Removal of Indications for Use of Oral Quinolones With Prescribing TrendsPhuong T Tran, Patrick J Antonelli, Juan M Hincapie-Castillo, et al.
The Annals of Pharmacotherapy|August 2, 2007
Systematic review of the incidence and characteristics of preventable adverse drug events in ambulatory careLinda Aagaard Thomsen, Almut G Winterstein, Birthe Søndergaard, et al.
BMC Infectious Diseases|August 8, 2022
RSV testing practice and positivity by patient demographics in the United States: integrated analyses of MarketScan and NREVSS databasesPhuong T Tran, Sabina O Nduaguba, Vakaramoko Diaby, et al.
The Journal of Clinical Psychiatry|July 8, 2017
Differential Risk of Increasing Psychotropic Polypharmacy Use in Children Diagnosed With ADHD as PreschoolersAlmut G Winterstein, Rene Soria-Saucedo, Tobias Gerhard, et al.
Pharmacoepidemiology and Drug Safety|March 17, 2010
Pre-existing cardiovascular conditions and pharmacological treatment of adult ADHDTobias Gerhard, Almut G Winterstein, Mark Olfson, et al.
Journal of Patient Safety|February 27, 2015
Development of a Medication Safety and Quality Survey for Small Rural HospitalsAlmut G Winterstein, Thomas E Johns, Kyle N Campbell, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|November 20, 2019
Appropriateness of Otic Quinolone Use among Privately Insured US PatientsPhuong T Tran, Almut G Winterstein, Xi Wang, et al.
Diabetes Care|July 20, 2023
A Road Map for Peer Review of Real-World Evidence Studies on Safety and Effectiveness of TreatmentsAlmut G Winterstein, Vera Ehrenstein, Jeffrey S Brown, et al.
Clinical Epidemiology|June 5, 2023
Adaptability of High Dimensional Propensity Score Procedure in the Transition from ICD-9 to ICD-10 in the US Healthcare SystemAmir Sarayani, Joshua D Brown, Christian Hampp, et al.
Pageof 24